PB PHASEBIO Trademark

Trademark Overview


On Wednesday, March 25, 2020, a trademark application was filed for PB PHASEBIO with the United States Patent and Trademark Office. The USPTO has given the PB PHASEBIO trademark a serial number of 88847647. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 16, 2023. This trademark is owned by PhaseBio Pharmaceuticals, Inc.. The PB PHASEBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations for treating orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceuticals comprising drugs based on recombinant Elastin-like polypeptides technology platform, namely, pharmaceuticals for treating heart disease, heart conditions, hypertension, pulmonary hypertension, other disorders of the cardiopulmonary system, and orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceutical preparations cons...

Medical and scientific research services, namely, medical research; medical and scientific research services all in the field of pharmaceuticals
pb phasebio

General Information


Serial Number88847647
Word MarkPB PHASEBIO
Filing DateWednesday, March 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements


Description of MarkThe mark consists of Stylized letters "P" and "B", intersecting such that they resemble a heart design slightly skewed to the right, to the left of the word "PHASEBIO".
Goods and ServicesPharmaceutical preparations for treating heart disease, heart conditions, hypertension, pulmonary hypertension, and other disorders of the cardiopulmonary system; pharmaceutical preparations for treating orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceuticals comprising drugs based on recombinant Elastin-like polypeptides technology platform, namely, pharmaceuticals for treating heart disease, heart conditions, hypertension, pulmonary hypertension, other disorders of the cardiopulmonary system, and orphan diseases, namely, cystic fibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy, achondroplasia, short bowel syndrome, hypoparathyroidism, systemic lupus erythematosus, insulin-like growth factor deficiency, growth hormone deficiency; pharmaceutical preparations consisting of reversal agents for counteracting the effects of platelet aggregation inhibitors
Pseudo MarkPHASE BIO PHASE BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical and scientific research services, namely, medical research; medical and scientific research services all in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhaseBio Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Party NamePhaseBio Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events


Event DateEvent Description
Monday, October 16, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2023SOU EXTENSION 5 GRANTED
Friday, March 10, 2023SOU EXTENSION 5 FILED
Wednesday, March 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 7, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, September 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 13, 2022SOU EXTENSION 4 GRANTED
Tuesday, September 13, 2022SOU EXTENSION 4 FILED
Tuesday, September 13, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 3 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 3 FILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021SOU EXTENSION 2 GRANTED
Monday, September 13, 2021SOU EXTENSION 2 FILED
Monday, September 13, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 15, 2021SOU EXTENSION 1 GRANTED
Monday, March 15, 2021SOU EXTENSION 1 FILED
Monday, March 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 28, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, August 25, 2020ASSIGNED TO PETITION STAFF
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 16, 2020ASSIGNED TO EXAMINER
Wednesday, April 1, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 31, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 28, 2020NEW APPLICATION ENTERED